INCY:NASDAQ
Incyte Corp
$115.30
arrow_downward
-1.57%(-1.84) 1D
$115.30
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 2, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
$116.76
High
$117.19
Low
$114.57
Mkt. cap
23.37B
Avg. vol.
1.45M
Volume
2.17M
P/E ratio
14.69
52-wk high
$132.58
52-wk low
$82.82
EPS
$7.85
Beta
0.74
Shares outstanding
202.70M
No. of employees
3K
Open
$116.76
High
$117.19
Low
$114.57
Mkt. cap
23.37B
Avg. vol.
1.45M
Volume
2.17M
P/E ratio
14.69
52-wk high
$132.58
52-wk low
$82.82
EPS
$7.85
Beta
0.74
Shares outstanding
202.70M
No. of employees
3K
News stories
From web sources and news partners
Investing.com Canada
·
8 hours ago
Form 4 Incyte Corporation For: 2 October By Investing.com
News Corp
·
10 hours ago
Incyte Corp. stock outperforms competitors despite losses on the day
MarketWatch
·
10 hours ago
Incyte Corp. stock outperforms competitors despite losses on the day
Stock Titan
·
11 hours ago
Shares replace quarterly director fees as Incyte (INCY) awards 206 fully vested shares.
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteincyte.com